Two new studies show it is
safe to treat some cancer patients who have low white blood cell counts
with oral antibiotics. Currently, most patients are given antibiotics intravenously
to prevent infection.
The new research, published in a recent issue of The New England
Journal of Medicine (Vol. 341, No. 5), suggests that if patients do
not have other complications, such as low blood pressure, lung problems,
or abdominal pain, giving oral antibiotics is just as safe. Patients with
low risk of complications were examined in the studies. The studies excluded
high-risk patients with other medical complications such as HIV infection
or stem-cell transplantation and patients who were expected to have low
white blood cell counts for longer than 10 days.
Giving oral antibiotics eliminates the need to give the patient antibiotics
intravenously, thus allowing some patients the option of outpatient treatment
because there is no need to give multiple daily infusions, said Winfried
V. Kern, MD, lead author of one of the studies. Also, the cost of therapy
is reduced, Dr. Kern said.
Data from one of the studies show oral antibiotics worked in 71 percent
of 116 patients, compared with 67 percent of the 116 patients who were
given intravenous antibiotics. The other study shows an 86 percent success
rate for the 177 patients receiving oral antibiotics, compared with an
84 percent success rate among the 176 people treated intravenously.
Because radiation and chemotherapy often decrease the number of infection-fighting
white blood cells in cancer patients, doctors give antibiotics at the first
sign of a fever to keep infections away. Treating patients with oral
antibiotics rather than intravenous antibiotics is more convenient and
less expensive because patients can be treated at home.
"Oral antibiotics are as safe as intravenous antibiotics if the patients
for oral therapy are carefully selected," said Dr. Kern. If the patient
is treated at home, however, careful rules for contacting the doctor in
case of a problem need to be established, Dr. Kern said.
Patients should not be pressed into using oral antibiotics instead of
intravenous treatment and should choose the oral therapy only after detailed
discussion with their doctor if they feel prepared for it, Dr. Kern added.
LaMar McGinnis, MD, medical consultant for the American Cancer Society
(ACS), believes the research is good news for patients and their families.
"This is a quality of life issue for many since it is easier to take antibiotics
by mouth than to be injected," he said.
Although some patients may feel they are being treated more vigorously
if they are given antibiotics intravenously, Dr. McGinnis said they should
feel confident about receiving oral antibiotics.
He cautions that there are some safety risks involved because patients
are not monitored as closely at home as they are in a hospital, but adds
there is a higher risk of infection in a hospital environment when compared
to a home environment. ACS News Center stories are provided as a source of cancer-related
news and are not intended to be used as
press releases.
|